| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
KARD
Kardigan, Inc.
|
Oct 29, 2026 | BUY |
Strong Buy
+203.3% avg upside
7 analysts
|
$50.00
253.87% Upside
|
-7.8% | Β· |
|
PTCT
PTC Therapeutics
|
Oct 29, 2026 | BUY |
Buy
+35.4% avg upside
29 analysts
|
$137.00
128.38% Upside
|
-6.4% | Β· |
|
SPRO
Spero Therapeutics
|
Oct 28, 2026 | BUY |
Buy
+1102.8% avg upside
13 analysts
|
$6.00
466.05% Upside
|
-23.1% | Β· |
|
DBVT
DBV Technologies SA - American
|
Oct 28, 2026 | BUY |
Buy
+143.7% avg upside
15 analysts
|
$48.00
405.71% Upside
|
-6.2% | Β· |
|
MYRG
MYR Group
|
Oct 28, 2026 | BUY |
Buy
+13.3% avg upside
15 analysts
|
$441.00
56.05% Upside
|
-4.5% | Β· |
|
PHAT
Phathom Pharmaceuticals
|
Oct 23, 2026 | BUY |
Strong Buy
+316.5% avg upside
15 analysts
|
β | -4.2% | Β· |
|
LXEO
Lexeo Therapeutics, Inc.
|
Oct 21, 2026 | BUY |
Strong Buy
+528.2% avg upside
11 analysts
|
$23.00
632.48% Upside
|
-4.7% | Β· |
|
IRON
Disc Medicine
|
Oct 19, 2026 | BUY |
Strong Buy
+23.5% avg upside
21 analysts
|
$170.00
110.34% Upside
|
-3.0% | Β· |
|
RNA
Atrium Therapeutics, Inc.
|
Oct 14, 2026 | BUY |
Strong Buy
+246.6% avg upside
6 analysts
|
$25.00
202.27% Upside
|
-15.6% | Β· |
|
CLDX
Celldex
|
Oct 13, 2026 | BUY |
Strong Buy
+43.0% avg upside
28 analysts
|
$72.00
139.19% Upside
|
-0.8% | Β· |
|
TSE:EPRX
Eupraxia Pharmaceuticals
|
Oct 07, 2026 | BUY |
Strong Buy
+122.3% avg upside
11 analysts
|
$26.55
178.97% Upside
|
-4.3% | Β· |
|
SE:EGTX
Egetis Therapeutics AB
|
Sep 29, 2026 | BUY |
Strong Buy
+228.0% avg upside
1 analyst
|
$33.00
228.03% Upside
|
+25.5% | Β· |
|
RARE
Ultragenyx Pharmaceutical
|
Sep 17, 2026 | BUY |
Strong Buy
+193.8% avg upside
36 analysts
|
$39.00
142.23% Upside
|
+15.2% | Β· |
|
MREO
Mereo Biopharma Group Plc
|
Sep 17, 2026 | BUY |
Strong Buy
+1238.5% avg upside
11 analysts
|
$3.00
936.21% Upside
|
-6.9% | Β· |
|
ABEO
Abeona Therapeutics
|
Sep 17, 2026 | BUY |
Strong Buy
+295.1% avg upside
18 analysts
|
$30.00
589.67% Upside
|
-53.5% | Β· |
|
SLDB
Solid Biosciences
|
Sep 15, 2026 | BUY |
Strong Buy
+176.4% avg upside
26 analysts
|
$26.00
319.39% Upside
|
-25.6% | Β· |
|
CAPR
Capricor Therapeutics
|
Aug 14, 2026 | BUY |
Strong Buy
+332.5% avg upside
12 analysts
|
$28.00
338.86% Upside
|
+26.5% | Β· |
|
MNPR
Monopar Therapeutics Inc
|
Aug 12, 2026 | HOLD |
Strong Buy
+51.0% avg upside
18 analysts
|
$119.00
69.27% Upside
|
-38.1% | Β· |
|
CDXS
Codexis
|
Aug 11, 2026 | BUY |
Strong Buy
+746.4% avg upside
13 analysts
|
$11.00
824.45% Upside
|
-27.7% | Β· |
|
TSHA
Taysha Gene Therapies
|
Aug 11, 2026 | BUY |
Strong Buy
+241.9% avg upside
22 analysts
|
$19.00
359.98% Upside
|
-40.1% | Β· |
|
RNAC
Cartesian Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+378.5% avg upside
19 analysts
|
$16.00
146.61% Upside
|
-21.3% | Β· |
|
ADMA
ADMA Biologics
|
Aug 05, 2026 | HOLD |
Strong Buy
-3.8% avg upside
15 analysts
|
$12.00
5.12% Upside
|
+47.2% | Β· |
|
ZVRA
Zevra Therapeutics
|
Aug 05, 2026 | BUY |
Strong Buy
+113.0% avg upside
15 analysts
|
$25.00
143.09% Upside
|
-10.7% | Β· |
|
SRPT
Sarepta Therapeutics
|
Aug 05, 2026 | HOLD |
Buy
+223.8% avg upside
50 analysts
|
$21.00
12.82% Upside
|
+0.7% | Β· |
|
RIGL
Rigel
|
Aug 04, 2026 | HOLD |
Strong Buy
-47.4% avg upside
17 analysts
|
$43.00
16.10% Downside
|
+10.9% | Β· |
|
SUPN
Supernus Pharmaceuticals
|
Jul 09, 2026 | BUY |
Strong Buy
+30.3% avg upside
9 analysts
|
$67.00
59.90% Upside
|
-7.9% | Β· |
|
AQST
Aquestive Therapeutics
|
Jun 25, 2026 | BUY |
Strong Buy
+131.4% avg upside
10 analysts
|
$11.00
182.74% Upside
|
-17.2% | Β· |
|
QURE
uniQure
|
Jun 17, 2026 | BUY |
Strong Buy
+121.1% avg upside
30 analysts
|
β | -56.9% | Β· |
|
FULC
Fulcrum Therapeutics
|
Mar 19, 2026 | BUY |
Hold
+169.6% avg upside
14 analysts
|
$24.00
546.87% Upside
|
-46.7% | Β· |
|
SKYE
Skye Bioscience
|
Mar 10, 2026 | HOLD |
Strong Buy
+3616.0% avg upside
9 analysts
|
$16.00
1149.91% Upside
|
-84.4% | Β· |
|
XFOR
X4 Pharmaceuticals
|
Nov 21, 2025 | BUY |
Strong Buy
+613.0% avg upside
16 analysts
|
$14.00
317.93% Upside
|
-17.6% | Β· |
|
HUMA
Humacyte
|
Jul 01, 2024 | BUY |
Strong Buy
+1468.9% avg upside
11 analysts
|
$7.00
1602.28% Upside
|
-57.5% | Β· |
|
IRD
Opus Genetics
|
May 13, 2024 | BUY |
Strong Buy
+231.4% avg upside
25 analysts
|
β | -42.9% | Β· |
|
LCTX
Lineage Therap
|
Feb 04, 2024 | BUY |
Strong Buy
+453.8% avg upside
16 analysts
|
$6.00
500.07% Upside
|
-36.5% | Β· |
|
OTLK
Outlook Therapeutics
|
Aug 30, 2023 | HOLD |
Buy
+1882.0% avg upside
11 analysts
|
$20.00
4172.62% Upside
|
+36.6% | Β· |
|
DRTS
Alpha Tau
|
Aug 28, 2023 | BUY |
Strong Buy
+7.2% avg upside
5 analysts
|
$23.00
76.10% Upside
|
-30.1% | Β· |
|
ATNM
Actinium Pharmaceuticals
|
Jun 28, 2023 | BUY |
Strong Buy
+364.2% avg upside
11 analysts
|
$27.00
1724.33% Upside
|
+0.5% | Β· |
|
DMRA
Damora Therapeutics
|
Jun 26, 2023 | BUY |
Strong Buy
+39.9% avg upside
20 analysts
|
$17.00
20.84% Downside
|
-80.6% | Β· |
|
CMMB
Chemomab Therapeutics
|
Jun 09, 2023 | HOLD |
Strong Buy
+2244.8% avg upside
6 analysts
|
β | -41.7% | Β· |
|
HEPA
Hepion Pharmaceuticals
|
May 15, 2023 | BUY |
Strong Buy
+27281.0% avg upside
9 analysts
|
$28.00
15455.62% Upside
|
Β· | Β· |
|
EVLO
Evelo Biosciences
|
Mar 16, 2023 | HOLD |
Buy
+44999900.0% avg upside
5 analysts
|
$20.00
19999900.06% Upside
|
Β· | Β· |
|
HTGMQ
HTG Molecular Diagnostics
|
Mar 10, 2023 | HOLD |
Strong Buy
+733333233.3% avg upside
6 analysts
|
β | Β· | Β· |
|
HLSQ
Tessera Defense and Homeland Security
|
Mar 10, 2023 | HOLD |
Buy
+14451.8% avg upside
4 analysts
|
β | Β· | Β· |
|
IBIO
Ibio
|
Dec 21, 2022 | HOLD |
Strong Buy
+672.4% avg upside
13 analysts
|
$10.00
1200.91% Upside
|
-84.8% | Β· |
|
EOCN
Eocene
|
Aug 04, 2022 | HOLD |
Buy
+688.3% avg upside
13 analysts
|
$10.50
238.67% Upside
|
Β· | Β· |
|
ERNA
Eterna Therapeutics
|
Dec 29, 2021 | BUY |
Strong Buy
+3554.9% avg upside
4 analysts
|
$180.00
9037.12% Upside
|
Β· | Β· |
|
OCGN
Ocugen
|
Sep 28, 2021 | HOLD |
Strong Buy
+1211.8% avg upside
17 analysts
|
$4.00
469.18% Upside
|
-71.6% | Β· |
|
MBIO
Mustang Bio
|
May 12, 2021 | BUY |
Strong Buy
+1587.1% avg upside
5 analysts
|
$10.00
2399.45% Upside
|
Β· | Β· |
|
SCPX
Scorpius Holdings
|
Mar 02, 2021 | BUY |
Strong Buy
+3051983.3% avg upside
11 analysts
|
$22.00
3666566.58% Upside
|
Β· | Β· |
|
EVGN
Evogene
|
Nov 30, 2020 | BUY |
Strong Buy
+2798.7% avg upside
6 analysts
|
$9.00
2302.55% Upside
|
Β· | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.